Drug: omalizumab Quarter: 2016Q3
Total Drug/Injury Combinations: 175 Number of Pages: 9
DRUGNAME | PT | EventCount | |
---|---|---|---|
Omalizumab | Red blood cell count increased | 18 | view events |
Omalizumab | Sense of oppression | 18 | view events |
Omalizumab | Sputum discoloured | 18 | view events |
Omalizumab | Varicose vein | 18 | view events |
Omalizumab | White blood cell count increased | 18 | view events |
Omalizumab | Exposure during pregnancy | 16 | view events |
Omalizumab | Perinatal depression | 13 | view events |
Omalizumab | Urinary incontinence | 13 | view events |
Omalizumab | Concomitant disease aggravated | 12 | view events |
Omalizumab | Gestational diabetes | 12 | view events |
Omalizumab | Gestational hypertension | 12 | view events |
Omalizumab | Hypoxia | 12 | view events |
Omalizumab | Nasal polyps | 12 | view events |
Omalizumab | Pharyngitis | 12 | view events |
Omalizumab | Premature labour | 12 | view events |
Omalizumab | Rhinitis allergic | 12 | view events |
Omalizumab | Anaemia | 11 | view events |
Omalizumab | Blood magnesium decreased | 11 | view events |
Omalizumab | Hypothyroidism | 11 | view events |
Omalizumab | Postural orthostatic tachycardia syndrome | 11 | view events |
Total Drug/Injury Combinations: 175 Number of Pages: 9
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)